title: Do we need a different strategy for HPV screening and vaccination in East Asia?
authors.forename: Shiho
authors.initials: S
authors.lastname: Miura
authors.forename: Koji
authors.initials: K
authors.lastname: Matsumoto
authors.forename: Akinori
authors.initials: A
authors.lastname: Oki
authors.forename: Toyomi
authors.initials: T
authors.lastname: Satoh
authors.forename: Hajime
authors.initials: H
authors.lastname: Tsunoda
authors.forename: Toshiharu
authors.initials: T
authors.lastname: Yasugi
authors.forename: Yuji
authors.initials: Y
authors.lastname: Taketani
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Yoshikawa
mesh_terms: D005202:Asia, Eastern / Q000453:epidemiology; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D015995:Prevalence; D013045:Species Specificity
chemical_list: D053918:Papillomavirus Vaccines